Free Trial

Target Healthcare REIT (LON:THRL) Sets New 52-Week High - Should You Buy?

Target Healthcare REIT logo with Real Estate background

Target Healthcare REIT (LON:THRL - Get Free Report) hit a new 52-week high during trading on Tuesday . The company traded as high as GBX 99 ($1.32) and last traded at GBX 98.60 ($1.32), with a volume of 192688 shares trading hands. The stock had previously closed at GBX 98.30 ($1.32).

Target Healthcare REIT Trading Down 0.1 %

The business has a 50 day simple moving average of GBX 90.10 and a 200 day simple moving average of GBX 87.02. The company has a debt-to-equity ratio of 34.92, a current ratio of 7.20 and a quick ratio of 1.52. The company has a market cap of £601.09 million, a price-to-earnings ratio of 8.23, a price-to-earnings-growth ratio of 1.48 and a beta of 0.44.

Target Healthcare REIT (LON:THRL - Get Free Report) last released its quarterly earnings results on Friday, March 14th. The company reported GBX 3.06 ($0.04) earnings per share (EPS) for the quarter. Target Healthcare REIT had a return on equity of 10.78% and a net margin of 104.99%. As a group, equities analysts forecast that Target Healthcare REIT will post 6.2219101 EPS for the current year.

About Target Healthcare REIT

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Target Healthcare REIT Right Now?

Before you consider Target Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Target Healthcare REIT wasn't on the list.

While Target Healthcare REIT currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines